Impact of Severe Brain Injury on Neuro-vascular and Endothelial Regulation of Peripheral Microcirculation.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-01

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe brain injury (SBI) is one of the world's leading causes of death and disability in young adults, but its peripheral vascular consequences in humans are poorly understood.

This prospective, monocentric, pathophysiological study aims to investigate differences in vasoreactivity in the anterior aspect of the contralateral forearm at the most injured cerebral hemisphere between patients with severe head trauma and patients with severe trauma without associated brain injury matched on sex and age (+/- 5 years).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Minor Traumatic Brain Injury : MRI Examination of Consequences and Social Insertion

NCT04364568

Traumatic Brain Injury

TERMINATED NA

A Study of Biomarkers of Mild Traumatic BRAIN Injury

NCT04032509

Mild Traumatic Brain Injury

COMPLETED

Transcranial Doppler on Admission of Patients With Mild to Moderate Traumatic Brain Injury

NCT01291706

Traumatic Brain Injury

COMPLETED

Identification of Predictive Neuroinflammatory Biomarkers of Neuro-radiological Evolution in Severe Traumatic Brain Injury

NCT03659006

Severe Traumatic Brain Injury

UNKNOWN NA

Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury

NCT04854954

Traumatic Brain Injury

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Severe brain injury (SBI) is one of the world's leading causes of death and disability in young adults.

Its impact on cerebral vascularization is well known. At the systemic level, it induces transient dysfunctions that can develop into severe failures, even in cases of isolated SBI. Studies on a mouse model of SBI show alterations in peripheral vascular reactivity that persist over time and are linked to endothelial dysfunction, the mechanism of which is a decoupling of endothelial NO synthase in a context of systemic inflammation. However, no data are available regarding the peripheral vascular consequences of SBI in humans.

The main objective of this prospective, monocentric, pathophysiological study is to determine whether the postocclusive hyperaemic response at the anterior surface of the contralateral forearm to the most injured cerebral hemisphere differs between patients with severe brain injury and patients with severe trauma without associated head injury matched on sex and age (+/- 5 years), by studying the amplitude of post-occlusive hyperaemia (maximum amplitude expressed as percentage of vasodilatation and area under the curve : AUC) as a function of the group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Traumatic Brain Injury Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Severe traumatic brain injury

No interventions assigned to this group

Severe trauma without brain trauma

No interventions assigned to this group

Healthy controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy volunteers :

* Men and women, over 18 years of age
* Affiliation to a social security scheme
* Signed Consent

Patients with Severe Brain Injury :

* Male and female, over 18 years of age
* Isolated severe brain injury, defined by an initial Glasgow score less than or equal to 8.
* Affiliation to a social security scheme
* Signed informed consent

Severe traumatized patients without associated severe brain injury:

* men and women, over 18 years of age
* severe trauma, defined by an Injury Severity Score (ISS) ≥ 16.
* absence of associated severe brain injury, defined by an initial Glasgow score less than or equal to 8.
* affiliation to or beneficiary of a social security scheme
* signed informed consent

Exclusion Criteria

* Hypersensitivity to lidocaine and/or prilocaine or to amide type local anesthetics or to any of the excipients of the cream.
* History of axillary lymph node dissection, trauma or axillary surgery
* Prohibited treatments and procedures :

* In patients with head trauma: ongoing treatment with systemic vasodilators (calcium channel blocker, milrinone).
* In healthy volunteers: no treatment will be authorized other than paracetamol, hormone supplementation (contraceptive pill, hormone therapy, thyroid hormones).
* Pregnant, parturient or breastfeeding women
* Subject in a period of exclusion from another study,
* Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure,
* Subject having exceeded the annual compensation threshold for testing
* Subject cannot be contacted in case of emergency

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes